A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention

Author:

Lu Hongzhou,Ai Jingwen,Shen Yinzhong,Li Yang,Li Tao,Zhou Xian,Zhang Haocheng,Zhang Qiran,Ling Yun,Wang Sheng,Qu Hongping,Gao Yuan,Li Yingchuan,Yu Kanglong,Zhu Duming,Zhu Hecheng,Tian Rui,Zeng Mei,Li Qiang,Song Yuanlin,Li Xiangyang,Xu Jinfu,Xu Jie,Mao Enqiang,Hu Bijie,Li Xin,Zhu Lei,Zhang Wenhong

Abstract

AbstractObjectiveTo describe and evaluate the impact of diseases control and prevention on epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai.DesignA retrospective descriptive studySettingChinaParticipantsEpidemiology information was collected from publicly accessible database. 265 patients admitted to Shanghai Public Health Center with confirmed COVID-19 were enrolled for clinical features analysis.Main outcome measurePrevention and control measures taken by Shanghai government, epidemiological, demographic, clinical, laboratory and radiology data were collected. Weibull distribution, Chi-square test, Fisher’s exact test, t test or Mann-Whitney U test were used in statistical analysis.ResultsCOVID-19 transmission rate within Shanghai had reduced over 99% than previous speculated, and the exponential growth has been stopped so far. Epidemic was characterized by the first stage mainly composed of imported cases and the second stage where >50% of cases were local. The incubation period was 6.4 (95% CI 5.3 to 7.6) days and the mean onset-admission interval was 5.5 days (95% CI, 5.1 to 5.9). Median time for COVID-19 progressed to severe diseases were 8.5 days (IQR: 4.8-11.0 days). By February 11th, proportion of patients being mild, moderate, severe and critically ill were 1.9%(5/265), 89.8%(238/265), 3.8%(10/265), 4.5%(12/265), respectively; 47 people in our cohort were discharged, and 1 patient died.ConclusionStrict controlling of the transmission rate at the early stage of an epidemic in metropolis can quickly prohibit the spread of the diseases. Controlling local clusters is the key to prevent outbreaks from imported cases. Most COVID-19 severe cases progressed within 14 days of disease onset. Multiple systemic laboratory abnormalities had been observed before significant respiratory dysfunction.

Publisher

Cold Spring Harbor Laboratory

Reference17 articles.

1. J. C. Chinese researchers reveal draft genome of virus implicated in Wuhan pneumonia outbreak. In. Washington, DC: American Association for the Advancement of Science https://www.sciencemag.org/news/2020/01/chinese-researchers-reveal-draft-genome-virus-implicated-wuhan-pneumonia-outbreak.

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. WHO names deadly virus from China as ‘COVID-19’. In. https://guardian.ng/news/who-names-deadly-virus-from-china-as-covid-19/.

4. Holshue ML , DeBolt C , Lindquist S , et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020:10.1056/NEJMoa2001191.

5. The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures

Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3